Edward McKenna

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Jennifer L. McQuade, Carrie R. Daniel, Kenneth R. Hess et al. · The Lancet Oncology · 2018 · 658 citations · Full text

Medicine, Dermatology, Oncology +14

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Aleksandar Sekulić, Michael R. Migden, Nicole Basset‐Séguin et al. · BMC Cancer · 2017 · 412 citations · Full text

Medicine, Oncology, Pharmacology +14

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

Stefan Glück, Jeffrey S. Ross, Melanie Royce et al. · Breast Cancer Research and Treatment · 2011 · 237 citations

Medicine, Oncology, Pharmacology +17

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Anne Lynn S. Chang, James Solomon, John D. Hainsworth et al. · Journal of the American Academy of Dermatology · 2013 · 188 citations · Full text

Medicine, Oncology, Pharmacology +8

5-Year Outcomes with Cobimetinib plus Vemurafenib in <i>BRAF</i> V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

Paolo A. Ascierto, Brigitte Dréno, James Larkin et al. · Clinical Cancer Research · 2021 · 182 citations · Full text

Medicine, Oncology, Pharmacotherapy +7